Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease

Current Understanding of Psychosis in Parkinson’s Disease

(2016) Oluwadamilola O. Ojo et al.   Current Psychiatry Reports

Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis

(2016) Harini Sarva et al.   Therapeutic Advances in Neurological Disorders

Is Occipital Cortex a Valid Reference Region in 123I-FP-CIT SPECT Imaging?

(2015) Juho Joutsa et al.   CLINICAL NUCLEAR MEDICINE

Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase

(2015) Javier Pagonabarraga et al.   MOVEMENT DISORDERS

Effects of aging and gender on striatal and extrastriatal [ 123 I]FP-CIT binding in Parkinson's disease

(2015) Valtteri Kaasinen et al.   NEUROBIOLOGY OF AGING

Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review

(2015) Abhishek Lenka et al.   PARKINSONISM & RELATED DISORDERS

Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease

(2014) Valtteri Kaasinen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Visual hallucinations in Parkinson's disease: Theoretical models

(2014) Alana J. Muller et al.   MOVEMENT DISORDERS

Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study

(2014) Lorenzo Kiferle et al.   PARKINSONISM & RELATED DISORDERS

Tricks of the mind: Visual hallucinations as disorders of attention

(2014) James M. Shine et al.   PROGRESS IN NEUROBIOLOGY

Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation

(2014) Katharina Stegmayer et al.   NeuroImage-Clinical

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes

(2013) Nin Bajaj et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Schizophrenia: an integrated sociodevelopmental-cognitive model

(2013) Oliver D Howes et al.   LANCET

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

(2012) Bernard Ravina et al.   MOVEMENT DISORDERS

Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia

(2012) Christian Sorg et al.   SCHIZOPHRENIA BULLETIN

Hallucinations in Neurodegenerative Diseases

(2011) Lothar Burghaus et al.   CNS Neuroscience & Therapeutics

FP-CIT SPECT Does Not Predict the Progression of Motor Symptoms in Parkinson’s Disease

(2011) Magdalena Hubbuch et al.   EUROPEAN NEUROLOGY

Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?

(2011) James M. Shine et al.   MOVEMENT DISORDERS

The Effect of Dopamine Agonists on Adaptive and Aberrant Salience in Parkinson's Disease

(2011) Helga Nagy et al.   NEUROPSYCHOPHARMACOLOGY

Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease

(2010) Benedicte Ballanger et al.   ARCHIVES OF NEUROLOGY

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

(2010) P. A. Kempster et al.   BRAIN

Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects

(2009) Robert M. Kessler et al.   BIOLOGICAL PSYCHIATRY

Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A123I-FP-CIT SPECT study

(2009) Francesco Roselli et al.   MOVEMENT DISORDERS

Hallucinations in Parkinson disease

(2009) Nico J. Diederich et al.   Nature Reviews Neurology

Role of dopamine receptor agonists in the treatment of early Parkinson's disease

(2009) Ubaldo Bonuccelli et al.   PARKINSONISM & RELATED DISORDERS